Prostate‐specific membrane antigen (PSMA) glycoforms in prostate cancer patients seminal plasma
The Prostate · 2024
DOI: 10.1002/pros.24666 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prostate, 2024. Verfasst von Stephen Mackay und 5 weiteren Autor:innen. Beteiligte Einrichtung: Leroy T. Canoles Jr. Cancer Research Center, Eastern Virginia Medical School, Norfolk, Virginia, USA. Hauptthemen laut MEDLINE: Prostate, Prostatic Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: US Department of Defense (DOD)/Congressionally Directed Medical Research Programs through the Prostate Cancer Research Program, Eastern Virginia Medical School Biorepository.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Introduction
Prostate‐specific membrane antigen (PSMA) is a US Food and Drug Administration‐approved theranostic target for prostate cancer (PCa). Although PSMA is known to be glycosylated, the composition and functional roles of its N‐linked glycoforms have not been fully characterized.
Methods
PSMA was isolated from pooled seminal plasma from low‐risk grade Groups 1 and 2 PCa patients. Intact glycopeptides were analyzed by mass spectrometry to identify site‐specific glycoforms.
Results
We observed a rich distribution of PSMA glycoforms in seminal plasma from low and low‐intermediate‐risk PCa patients. Some interesting generalities can be drawn based on the predicted topology of PSMA on the plasma membrane. The glycoforms at ASN‐459, ASN‐476, and ASN‐638 residues that are located at the basal domain facing the plasma membrane in cells, are predominantly high mannose glycans. ASN‐76 which is located in the interdomain region adjacent to the apical domain of the protein shows a mixture of high mannose glycans and complex glycans, whereas ASN‐121, ASN‐195 and ASN‐336 that are located and are exposed at the apical domain of the protein predominantly possess complex sialylated and fucosylated N‐linked glycans. These highly accessible glycosites display the greatest diversity in isoforms across the patient samples.
Conclusions
Our study provides novel qualitative insights into PSMA glycoforms that are present in the seminal fluid of PCa patients. The presence of a rich diversity of glycoforms in seminal plasma provides untapped potential for glycoprotein biomarker discovery and as a clinical sample for noninvasive diagnostics of male urological disorders and diseases including PCa. Specifically, our glycomics approach will be critical in uncovering PSMA glycoforms with utility in staging and risk stratification of PCa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leroy T. Canoles Jr. Cancer Research Center, Eastern Virginia Medical School, Norfolk, Virginia, USA.
- Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, Virginia, USA.
- Department of Neonatal-Perinatal Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
- Department of Neurology, Children's Hospital of the Kings Daughters, Norfolk, Virginia, USA.
ORCID-Profile: Julius O Nyalwidhe
Förderung
- US Department of Defense (DOD)/Congressionally Directed Medical Research Programs through the Prostate Cancer Research Program
- Eastern Virginia Medical School Biorepository
Zitieren
APA
Mackay, S., Oduor, I. O., Burch, T. C., Troyer, D. A., Semmes, O. J., & Nyalwidhe, J. O. (2024). Prostate‐specific membrane antigen (PSMA) glycoforms in prostate cancer patients seminal plasma. The Prostate. https://doi.org/10.1002/pros.24666
Vancouver
Mackay S, Oduor IO, Burch TC, Troyer DA, Semmes OJ, Nyalwidhe JO. Prostate‐specific membrane antigen (PSMA) glycoforms in prostate cancer patients seminal plasma. The Prostate. 2024. doi:10.1002/pros.24666
BibTeX
@article{Mackay2024,
author = {Mackay, Stephen and Oduor, Ian O and Burch, Tanya C and Troyer, Dean A and Semmes, Oliver J and Nyalwidhe, Julius O},
title = {Prostate‐specific membrane antigen (PSMA) glycoforms in prostate cancer patients seminal plasma},
journal = {The Prostate},
year = {2024},
doi = {10.1002/pros.24666}
}
EUVIMED